Lung Cancer
News
HIV drug may enhance efficacy of chemoradiation in locally advanced lung cancer
Strategy incorporating protease inhibitor nelfinavir yields promising efficacy, acceptable toxicity in locally advanced non–small cell lung cancer...
Original Research
Timely Diagnosis of Lung Cancer in a Dedicated VA Referral Unit with Endobronchial Ultrasound Capability
A dedicated referral clinic with pulmonary consultation and aA dedicated referral clinic with pulmonary consultation and access to diagnostic...
News
Immune-related toxicities, hospitalization common with checkpoint inhibitor therapy
The most common immune-related adverse events warranting hospital admission were pneumonitis and colitis.
News
Bevacizumab or pemetrexed, but not both, efficacious for NSCLC maintenance
The combination of bevacizumab and pemetrexed did not improve survival and had significantly worse toxicity than bevacizumab alone.
News
COPD adds complexity to shared decision making for LDCT lung cancer screening
Current guidelines stress the importance of shared decision making, with discussion of the risks and benefits of screening.
News
Real-world data for immunotherapy-treated NSCLC found robust
Endpoints seen among patients treated with PD-1/PD-L1 inhibitors in real-world settings were consistent within data sets and similar to those...
News
Hurricanes delay RT, worsening survival of NSCLC
Patients undergoing definitive radiotherapy during a declaration of hurricane disaster had a 21-day longer radiation treatment duration and were...
News
Smoking-cessation attempts changed little over 7-year span
“Smokers should be encouraged to keep trying to quit until they succeed, and health care providers should be encouraged to keep supporting smokers...
News
Immunotherapy-treated NSCLC: Adverse impact of steroids driven by palliative indications
A new analysis suggests use of steroids for cancer-related palliation in patients with poor prognosis largely explains their association with...
Conference Coverage
Nicotine replacement therapy beats varenicline for smokers with OUD
SAN ANTONIO – “Results suggest it may be preferable to offer smokers with opioid use disorder [nicotine replacement therapy] rather than...